Search hospitals > Missouri > Kansas City
Children's Mercy Hospital
Claim this profileKansas City, Missouri 64108
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Neuroblastoma
Conducts research for Lymphoma
841 reported clinical trials
48 medical researchers
Summary
Children's Mercy Hospital is a medical facility located in Kansas City, Missouri. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Neuroblastoma, Lymphoma and other specialties. Children's Mercy Hospital is involved with conducting 841 clinical trials across 998 conditions. There are 48 research doctors associated with this hospital, such as Keith J. August, Kevin F. Ginn, John Anderson, MD, and Wayne Moore, MD, PhD.Area of expertise
1Leukemia
Global LeaderStage II
Philadelphia chromosome positive
NTRK1 positive
2Tumors
Global LeaderStage IV
Stage I
Stage II
Top PIs
Keith J. AugustChildren's Mercy Hospitals and Clinics4 years of reported clinical research
Expert in Tumors
Expert in Leukemia
53 reported clinical trials
110 drugs studied
Kevin F. GinnChildren's Mercy Hospitals and Clinics7 years of reported clinical research
Expert in Recurrence
Expert in Tumors
36 reported clinical trials
58 drugs studied
John Anderson, MDClinical Research Center of Alabama4 years of reported clinical research
Studies Angioedema
Studies Hereditary Angioedema
9 reported clinical trials
11 drugs studied
Wayne Moore, MD, PhDThe Children's Mercy Hospital1 year of reported clinical research
Studies Type 1 Diabetes
Studies Diabetes
7 reported clinical trials
10 drugs studied
Clinical Trials running at Children's Mercy Hospital
Brain Tumor
Osteosarcoma
Germ Cell Tumors
Neuroblastoma
Lymphoma
Rhabdomyosarcoma
Rhabdoid Tumor
Non-Hodgkin's Lymphoma
Tumors
Astrocytoma
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Children's Mercy Hospital?
Children's Mercy Hospital is a medical facility located in Kansas City, Missouri. This center is recognized for care of Leukemia, Tumors, Lymphoblastic Leukemia-Lymphoma, Neuroblastoma, Lymphoma and other specialties. Children's Mercy Hospital is involved with conducting 841 clinical trials across 998 conditions. There are 48 research doctors associated with this hospital, such as Keith J. August, Kevin F. Ginn, John Anderson, MD, and Wayne Moore, MD, PhD.
Where is Children's Mercy Hospital located?
Children's Mercy Hospital, headquartered at 2401 Gillham Road, Kansas City, MO 64108, offers comprehensive healthcare services across multiple locations. For urgent care needs, facilities are available in Overland Park, KS; Blue Valley, KS; East Independence, MO; West Kansas City, KS; Joplin, MO; Junction City, KS; and Wichita, KS. This network ensures accessible and specialized care for children throughout the region.
Who should I call to ask about financial aid or insurance network?
**Financial Assistance at Children's Mercy Hospital:**
- For financial assistance inquiries, contact the Admissions Financial Counseling department at admfc@cmh.edu or (816) 234-3567.
- For payment arrangements, reach out to Patient Financial Services at (816) 701-5100 or toll-free at (866) 572-0157.
- To apply, complete the online Financial Assistance Application or submit the printed form with proof of residency, pay stubs, and recent tax returns via mail, email, or fax.
What insurance does Children's Mercy Hospital accept?
Children's Mercy Hospital accepts a wide range of insurance plans, including commercial, Medicare, and Medicaid from various local and national carriers. The hospital offers the Children's Mercy Take CARE plan for its team members working at least 30 hours per week, with medical plans administered by Cigna, featuring the Gold, Blue, and Green Plans. It is crucial to verify coverage and restrictions with your insurance provider before scheduling visits to ensure services are covered.
What awards or recognition has Children's Mercy Hospital received?
Children's Mercy Hospital in Kansas City, Missouri, is renowned for its exceptional research and care efforts. It has been awarded the "Chronic Kidney Disease in Children" Study Award by the Children's Mercy Research Institute (CMRI), highlighting its commitment to improving children's health. Furthermore, the CMRI has achieved AAHRPP accreditation, demonstrating its dedication to quality and protection for participants in clinical studies, and the hospital is recognized as a Joy in Medicineâ„¢ organization by the American Medical Association (AMA).